Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2013
09/19/2013US20130247240 Tomato hybrid ps 02353389 and parents thereof
09/19/2013US20130247239 Pepper hybrid svr 14866143
09/19/2013US20130247238 Bean variety waxc6v1003
09/19/2013US20130247237 Novel garden bean sb4534
09/19/2013US20130245618 Controlled laser treatment for non-invasive tissue alteration, treatment and diagnostics with minimal collateral damage
09/19/2013US20130245245 Methods and compositions for isolating small rna molecules
09/19/2013US20130245243 Functional ligands to target molecules
09/19/2013US20130245238 Fibronectin Binding Domains with Reduced Immunogenicity
09/19/2013US20130245228 Isolation, Cloning, Sequencing and Functional analysis of ß-casein promoter along with the regions of exon1, intron1 and exon2 using mammary gland derived cell line of Buffalo (Bubulus bubalis)
09/19/2013US20130245099 Antagonat compositions and methods of use
09/19/2013US20130245098 RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
09/19/2013US20130245097 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes
09/19/2013US20130245095 Treatment of sialidase 4 (neu4) related diseases by inhibition of natural antisense transcript to neu4
09/19/2013US20130245094 APTZAYME CAPABLE OF SELECTIVE SILENCING OF TARGET miRNA BY RELEASING AN ANTISENSE SEQUENCE IN HEPATITIS C VIRUS-INFECTED CELLS AND USE THEREOF
09/19/2013US20130245092 Micro-rnas that control myosin expression and myofiber identity
09/19/2013US20130245090 Identification of novel genes coding for small temporal rnas
09/19/2013US20130245037 Stabilization of Hypoxia Inducible Factor (HIF) Alpha
09/19/2013US20130244927 Polynucleotides encoding signal peptide-containing molecules
09/19/2013US20130244907 Method for preparing b cell which produces human-type antibody
09/19/2013US20130244904 Escherichia coli having a modified translational property
09/19/2013US20130244883 Molecular Display Method
09/19/2013US20130244332 Taregted integration and expression of exogenous nucleic acid sequences
09/19/2013US20130244331 Recombinant virus production using mammalian cells in suspension
09/19/2013US20130244330 Novel Substitution Mutant Receptors and Their Use in a Nuclear Receptor-Based Inducible Gene Expression System
09/19/2013US20130244327 RNAi Sequence-Independent Modification Formats, and Stabilized Forms Thereof
09/19/2013US20130244307 Compositions relating to a mutant clostridium difficile toxin and methods thereof
09/19/2013US20130244303 Overexpression of phytase genes in yeast systems
09/19/2013US20130244295 Biofuel Production
09/19/2013US20130244289 Variant humicola grisea cbh1.1
09/19/2013US20130244286 COMPOSITIONS AND METHODS FOR cDNA SYNTHESIS
09/19/2013US20130244280 Expression vector for high level expression of recombinant proteins
09/19/2013US20130244277 Gene Expression Technique
09/19/2013US20130244276 Production of proteins in filamentous fungi
09/19/2013US20130244247 Strains of saccharomyces cerevisiae
09/19/2013US20130244246 Immortalized avian cell lines comprising e1a nucleic acid sequences
09/19/2013US20130244245 Orthogonal Translation Components for the in Vivo Incorporation of Unnatural Amino Acids
09/19/2013US20130244243 Method for producing expression product of exogenous gene in yeast, regulator of expression in yeast, and use thereof
09/19/2013US20130244231 Novel expression vector
09/19/2013US20130243931 Multileaf spinach
09/19/2013US20130243849 Compositions And Methods For Inhibiting Expression Of The HAMP Gene
09/19/2013US20130243813 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
09/19/2013US20130243812 Replication-Defective Flavivirus Vaccines and Vaccine Vectors
09/19/2013US20130243811 Immunostimulatory oligonucleotides and uses thereof
09/19/2013US20130243809 Recombinant flaviviral constructs and uses thereof
09/19/2013US20130243796 Genetic products differentially expressed in tumors and use thereof
09/19/2013US20130243789 Multiple Gene Expression Including sORF Constructs and Methods with Polyproteins, Pro-Proteins and Proteolysis
09/19/2013US20130243781 Signal peptide-containing proteins
09/19/2013US20130243780 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof
09/19/2013US20130243773 Recombinant production of mixtures of antibodies
09/19/2013US20130243769 Induced internalization of surface receptors
09/19/2013US20130243768 Multimeric proteins and methods of making and using same
09/19/2013US20130243765 Chimeric protein
09/19/2013US20130243755 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
09/19/2013US20130243744 Method of production of recombinant glycoproteins with increased circulatory half-life in mammalian cells
09/19/2013US20130243731 Oncolytic adenoviral vectors coding for monoclonal anti-ctla-4 antibodies
09/19/2013US20130243728 Recombinant microorganisms
09/19/2013US20130243724 Compositions and methods for inducing migration by dendritic cells and an immune response
09/19/2013US20130243126 Method and apparatus for data transmission using multiple transmit antennas
09/18/2013EP2639587A1 Reaction plate assembly, reaction plate and nucleic acid analysis device
09/18/2013EP2639311A1 Genetic testing method and testing apparatus
09/18/2013EP2639309A2 Membrane protein expression vector comprising a fusion partner consisting of the envelope protein p9 of cystovirus phi 12, and a membrane protein production method using the same
09/18/2013EP2639308A1 Enzymatic omega-oxidation and -amination of fatty acids
09/18/2013EP2639307A2 Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton
09/18/2013EP2639306A1 Coryneform bacterium transformant and method for producing phenol using same
09/18/2013EP2639305A1 Markers for detecting human follicular helper t cells and method for detecting human follicular helper t cells
09/18/2013EP2639304A1 Method for detecting nucleic acid, method for optically observing sample, and phosphor
09/18/2013EP2639303A1 Novel expression vector
09/18/2013EP2639302A1 Modified fluorescent protein
09/18/2013EP2639300A2 Production of nucleic acid
09/18/2013EP2639297A1 Method for producing peripheral blood monocyte-derived pluripotent stem cells
09/18/2013EP2639295A1 Coryneform bacterium transformant and method for producing phenol using same
09/18/2013EP2638912A1 Compositions containing antisense oligonucleotide to micro rna
09/18/2013EP2638399A1 Stimuli-responsive polymer diagnostic assay comprising magnetic nanoparticles and capture conjugates
09/18/2013EP2638177A2 Classification of nucleic acid templates
09/18/2013EP2638167A2 Dominant negative mutant kip-related proteins (krp) in zea mays and methods of their use
09/18/2013EP2638166A1 Plants having enhanced yield-related traits and method for making the same
09/18/2013EP2638165A1 Method for producing terpenes
09/18/2013EP2638164A1 Specific ligand for annexin 2
09/18/2013EP2638163A1 Polycomb-associated non-coding rnas
09/18/2013EP2638162A2 Skin permeating and cell entering (space) peptides and methods of use thereof
09/18/2013EP2638161A1 Antisense antibacterial compounds and methods
09/18/2013EP2638160A2 Nuclions and ribocapsids
09/18/2013EP2638159A2 Compositions, kits and methods for treatment of cardiovascular, immunological, and inflammatory diseases
09/18/2013EP2638158A1 Compositions, cells, kits and methods for autologous stem cell therapy
09/18/2013EP2638157A2 Methods and devices for nucleic acids synthesis
09/18/2013EP2638156A1 Method and device for isolating and purifying double-stranded nucleic acids
09/18/2013EP2638155A1 Cells & vertebrates for enhanced somatic hypermutation and class switch recombination
09/18/2013EP2638153A1 Polypeptides having endoglucanase activity and polynucleotides encoding same
09/18/2013EP2638151A1 Laccases and uses thereof
09/18/2013EP2638073A2 Protein complexes for antigen binding and methods of use
09/18/2013EP2638061A1 Soluble pd-1 variants, fusion constructs, and uses thereof
09/18/2013EP2638057A1 Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom
09/18/2013EP2637693A2 System and method for generating micro-seismic events and characterizing properties of a medium with non-linear acoustic interactions
09/18/2013EP2637687A1 Vaccines comprising non-specific nucleoside hydrolase and sterol 24-c-methyltransferase (smt) polypeptides for the treatment and diagnosis of leishmaniasis
09/18/2013EP2637673A1 Materials and methods related to microrna-21, mismatch repair, and colorectal cancer
09/18/2013EP2637515A1 Polypeptides Having Glucoamylase Activity and Polynucleotides Encoding Same
09/18/2013EP2319932B1 Novel herbicide resistance gene
09/18/2013CN1965078B Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
09/18/2013CN1694959B Non-sequence complementary antiviral oligonucleotides
09/18/2013CN1630665B Anti-A beta antibodies and their use
1 ... 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 ... 4023